LCTX 10-Q: SEC filing

Lineage Cell Therapeutics

Filed with the SEC on · accession 0001193125-26-458487

LCTX filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -10.8% by the first close after the filing.

Summary of the filing

Lineage Cell Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results, including collaboration revenues, license fees, and ATM equity sales activity.

Key details

FilerLineage Cell Therapeutics, Inc.
Collaboration partnerRoche
SubsidiaryCell Cure Neurosciences Ltd.
Licensing counterpartyHadasit Medical Research Services and Development Ltd.
Licensing counterpartyES Cell International Pte Ltd
ShareholderBroadwood Partners LP

How LCTX stock reacted

Close before

$1.11

Nov 11, 2026

First close after

-10.78%

$0.99

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for LCTX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for LCTX?

Click here

Frequently asked questions

What did LCTX file with the SEC on Nov 12, 2026?

LCTX filed a 10-Q (SEC filing). Lineage Cell Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results, including collaboration revenues, license fees, and ATM equity sales activity.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did LCTX stock react to this filing?

LCTX closed at $1.11 before the filing and $0.99 on Nov 12, 2026 (-10.78%).

Other LCTX SEC filings

Get alerts when LCTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days